Genetic Influences in Breast Cancer Drug Resistance.
作者： Melisa Intan Barliana , Rizky Abdulah , Adhitiya Daniyal , Ivana Santoso , Nadira Hasna Putri Gunawan
DOI: 10.2147/BCTT.S284453
关键词:
摘要: Breast cancer is the most common cancer in adult women aged 20 to 50 years. The therapeutic regimens that are commonly recommended to treat breast cancer are human epidermal growth factor receptor 2 (HER2) targeted therapy, endocrine therapy, and systemic chemotherapy. The selection of pharmacotherapy is based on the characteristics of the tumor and its hormone receptor status, specifically, the presence of HER2, progesterone receptors, and estrogen receptors. Breast cancer pharmacotherapy often gives different …
sci-hub.st 参考文章(202)
Peptanariu D, Marinca M, Miron L, Negură L, Research on aromatase gene (CYP19A1) polymorphisms as a predictor of endocrine therapy effectiveness in breast cancer. Revista medico-chirurgicală̆ a Societă̆ţ̜ii de Medici ş̧i Naturaliş̧ti din Iaş̧i. ,vol. 116, pp. 997- 1004 ,(2012)
Dian-Ke Yu, Bing-He Xu, Dong-Xin Lin, Bai-Lin Zhang, Bao-Ning Zhang, Tong Sun, Guo-Ji Chen, Xiang Wang, Shan Zheng, Ning Lü, Polymorphisms of GSTP1 is associated with differences of chemotherapy response and toxicity in breast cancer. Chinese Medical Journal. ,vol. 124, pp. 199- 204 ,(2011)
Li Shean Toh, Pauline Siew Mei Lai, David Bin-Chia Wu, Kok Thong Wong, Bee Yean Low, Claire Anderson, The Development and Validation of the Osteoporosis Prevention and Awareness Tool (OPAAT) in Malaysia PLOS ONE. ,vol. 10, pp. e0124553- 19 ,(2015) , 10.1371/JOURNAL.PONE.0124553
Hari Prasad Dhakal, Bjørn Naume, Marit Synnestvedt, Elin Borgen, Rolf Kaaresen, Ellen Schlichting, Gro Wiedswang, Assia Bassarova, Ruth Holm, Karl-Erik Giercksky, Jahn M Nesland, Expression of vascular endothelial growth factor and vascular endothelial growth factor receptors 1 and 2 in invasive breast carcinoma: prognostic significance and relationship with markers for aggressiveness. Histopathology. ,vol. 61, pp. 350- 364 ,(2012) , 10.1111/J.1365-2559.2012.04223.X
Grant Morahan, Dexing Huang, Susie I. Ymer, Michael R. Cancilla, Katrina Stephen, Preeti Dabadghao, George Werther, Brian D. Tait, Leonard C. Harrison, Peter G. Colman, Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele Nature Genetics. ,vol. 27, pp. 218- 221 ,(2001) , 10.1038/84872
Robert L Shields, Angela K Namenuk, Kyu Hong, Y Gloria Meng, Julie Rae, John Briggs, Dong Xie, Jadine Lai, Andrew Stadlen, Betty Li, Judith A Fox, Leonard G Presta, None, High Resolution Mapping of the Binding Site on Human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and Design of IgG1 Variants with Improved Binding to the FcγR Journal of Biological Chemistry. ,vol. 276, pp. 6591- 6604 ,(2001) , 10.1074/JBC.M009483200
Rik Derynck, Rosemary J. Akhurst, Allan Balmain, TGF-beta signaling in tumor suppression and cancer progression. Nature Genetics. ,vol. 29, pp. 117- 129 ,(2001) , 10.1038/NG1001-117
Joseph T. DiPiro, Pharmacotherapy: A Pathophysiologic Approach ,(1992)
Osvaldo Artigalás, Tazio Vanni, Mara Helena Hutz, Patricia Ashton-Prolla, Ida Vanessa Schwartz, None, Influence of CYP19A1 polymorphisms on the treatment of breast cancer with aromatase inhibitors: a systematic review and meta-analysis BMC Medicine. ,vol. 13, pp. 139- 139 ,(2015) , 10.1186/S12916-015-0373-9
Louise J Barber, Shahneen Sandhu, Lina Chen, James Campbell, Iwanka Kozarewa, Kerry Fenwick, Ioannis Assiotis, Daniel Nava Rodrigues, Jorge S Reis-Filho, Victor Moreno, Joaquin Mateo, L Rhoda Molife, Johann De Bono, Stan Kaye, Christopher J Lord, Alan Ashworth, Secondary mutations in BRCA2 associated with clinical resistance to a PARP inhibitor. The Journal of Pathology. ,vol. 229, pp. 422- 429 ,(2013) , 10.1002/PATH.4140